BBridgeBio Oncology Therapeutics, Inc. logo
BBOT//CIK 0001869105

BridgeBio Oncology Therapeutics, Inc.

Exchange

Nasdaq

Entity type

operating

Fiscal year end

Dec 31

Headquarters

DE